TQ-B3233

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQ-B3233, covering 2018-03-05 to 2018-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Tolerance and Pharmacokinetics of TQ-B3233 [Phase 1]